Rho (D) immune globulin
Paul A. Pham, Pharm.D., John G. Bartlett, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rho (D) negative women to reduce likelihood of hemolytic disease in Rho (D) -positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rho (D)-positive pts.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.